Acadian Asset Management
TXG icon

Acadian Asset Management’s 10x Genomics TXG Stock Holding History

Acadian Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34M Sell
61,160
-927
-1% -$24.3K ﹤0.01% 1037
2026
Q1 		$1.31M Sell
62,087
-36,184
-37% -$723K ﹤0.01% 1078
2025
Q4 		$1.6M Buy
98,271
+11,063
+13% +$167K ﹤0.01% 980
2025
Q3 		$1.02M Sell
87,208
-535,930
-86% -$6.99M ﹤0.01% 1052
2025
Q2 		$7.21M Buy
623,138
+216,733
+53% +$1.98M 0.01% 495
2025
Q1 		$3.54M Buy
406,405
+254,607
+168% +$3.21M 0.01% 604
2024
Q4 		$2.18M Buy
+151,798
New +$2.4M 0.01% 745
2021
Q2 		– Sell
-178
Closed -$32K – 2218
2021
Q1 		$32K Sell
178
-1,208
-87% -$209K ﹤0.01% 1906
2020
Q4 		$197K Buy
+1,386
New +$201K ﹤0.01% 1556
2020
Q3 		– Sell
-389
Closed -$35K – 2359
2020
Q2 		$35K Buy
+389
New +$30.3K ﹤0.01% 2006

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Acadian Asset Management's TXG Position: Q2 2026 in Review

Acadian Asset Management reduced its 10x Genomics (TXG) stake by 1.5% in Q2 2026, selling an estimated $24.3K and leaving 61,160 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1037.

Acadian Asset Management first reported a position in TXG in Q2 2020 and has held it in 10 quarters since. The position peaked at $7.21M in Q2 2025. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Acadian Asset Management held 61,160 shares of 10x Genomics worth $2.34M as of Q2 2026.
  • Acadian Asset Management sold 927 10x Genomics shares in Q2 2026, an estimated $24.3K.
  • 10x Genomics made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1037 holding.
  • Acadian Asset Management first reported a position in 10x Genomics in Q2 2020 and has held it in 10 quarters since.
  • Acadian Asset Management's 10x Genomics position peaked at $7.21M in Q2 2025.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.